Clopidogrel, Genetics, and Drug Responsiveness.

被引：35

作者：

Freedman, Jane E. ^{[1
]}

Hylek, Elaine M. ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 360卷 / 04期

关键词：

OF-FUNCTION POLYMORPHISM; PLATELET REACTIVITY; ASPIRIN RESISTANCE; VARIABILITY; CYP2C19;

D O I：

10.1056/NEJMe0810513

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：411 / 413

页数：3

共 14 条

[1] Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel [J].

Angiolillo, Dominick J. ;

Fernandez-Ortiz, Antonio ;

Bernardo, Esther ;

Ramirez, Celia ;

Cavallari, Ugo ;

Trabetti, Elisabetta ;

Sabate, Manel ;

Hernandez, Rosana ;

Moreno, Raul ;

Escaned, Javier ;

Alfonso, Fernando ;

Banuelos, Camino ;

Costa, Marco A. ;

Bass, Theodore A. ;

Pignatti, Pier Franco ;

Macaya, Carlos .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) :1895-1900

[2] Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel [J].

Brandt, J. T. ;

Close, S. L. ;

Iturria, S. J. ;

Payne, C. D. ;

Farid, N. A. ;

Ernest, C. S., II ;

Lachno, D. R. ;

Salazar, D. ;

Winters, K. J. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (12) :2429-2436

[3] Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway - A 700-patient study of aspirin resistance [J].

Frelinger, Andrew L., III ;

Furman, Mark I. ;

Linden, Matthew D. ;

Li, Youfu ;

Fox, Marsha L. ;

Barnard, Marc R. ;

Michelson, Alan D. .

CIRCULATION, 2006, 113 (25) :2888-2896

[4] Effect of cytochrome P450 polymorphisms on platelet reactivity after treatment with Clopidogrel in acute coronary syndrome [J].

Frere, Corinne ;

Cuisset, Thomas ;

Morange, Pierre-Emmanuel ;

Qpilici, Jacques ;

Camoin-Jaumd, Laurence ;

Saut, Noemie ;

Faille, Dorothee ;

Lambert, Marc ;

Juhan-Vague, Irene ;

Bonnet, Jean-Louis ;

Alessi, Marie-Christine .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (08) :1088-1093

[5] Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin [J].

Gilard, Martine ;

Arnaud, Bertrand ;

Cornily, Jean-Christophe ;

Le Gal, Gregoire ;

Lacut, Karine ;

Le Calvez, Genevive ;

Mansourati, Jacques ;

Mottier, Dominique ;

Abgrall, Jean-Francois ;

Boschat, Jacques .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) :256-260

[6] Cytochrome P4502C19 loss-of-function polymorphism, but not CYP3A4 IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients [J].

Giusti, Betti ;

Gori, Anna Maria ;

Marcucci, Rossella ;

Saracini, Claudia ;

Sestini, Ilaria ;

Paniccia, Rita ;

Valente, Serafina ;

Antoniucci, Davide ;

Abbate, Rosanna ;

Gensini, Gian Franco .

PHARMACOGENETICS AND GENOMICS, 2007, 17 (12) :1057-1064

[7] Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects [J].

Hulot, Jean-Sebastien ;

Bura, Alessandra ;

Villard, Eric ;

Azizi, Michel ;

Remones, Veronique ;

Goyenvalle, Catherine ;

Aiach, Martine ;

Lechat, Philippe ;

Gaussem, Pascale .

BLOOD, 2006, 108 (07) :2244-2247

[8] The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: A possible mechanism for clopidogrel resistance [J].

Kim, K. A. ;

Park, P. W. ;

Hong, S. J. ;

Park, J-Y .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) :236-242

[9]

LLOYDJONES D, 2008, CIRCULATION 1215

[10] Aspirin resistance and atherothrombotic disease [J].

Mason, PJ ;

Jacobs, AK ;

Freedman, JE .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) :986-993

← 1 2 →